At-risk patients still predisposed for myocardial infarction by coxibs




Helin-Salmivaara A, Martikainen JE

PublisherSPRINGER

2007

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

EUR J CLIN PHARMACOL

63

1

97

98

2

0031-6970

DOIhttps://doi.org/10.1007/s00228-006-0232-x




Last updated on 2024-26-11 at 12:32